Granules India receives USFDA approval for Loratadine Tablets
Granules India has received US Food & Drug Administration (USFDA) approval for Abbreviated New Drug Application filed forLoratadine Tablets USP, 10 mg (OTC). The approved ANDA is the bioequivalent to the Reference Listed Drug (RLD), Claritin Tablets 10 mg by Bayer HealthCare LLC. Granules India intends to commercialise this product shortly.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 24 2019 | 1:16 PM IST